M 515 (Mirtazapine 15 mg)

Pill with imprint M 515 is Beige, Round and has been identified as Mirtazapine 15 mg. It is supplied by Mylan Pharmaceuticals Inc..

Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 515

Mirtazapine

Imprint:

M 515

Strength:

15 mg

Color:

Beige

Size:

7.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Tetracyclic antidepressants

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Mylan Pharmaceuticals Inc.

Inactive Ingredients:

• lactose anhydrous
• silicon dioxide
• croscarmellose sodium
• FD&C Blue No. 2
• FD&C Yellow No. 6
• hypromelloses
• magnesium stearate
• microcrystalline cellulose
• polydextrose
• polyethylene glycol
• corn starch
• sodium lauryl sulfate
• titanium dioxide
• triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00378-3515	Mylan Pharmaceuticals Inc.
51079-0086	UDL Laboratories Inc.
54569-5895	A-S Medication Solutions, LLC (repackager)

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer